Literature DB >> 29484159

Monitoring adolescents and young people with inflammatory bowel disease during transition to adult healthcare.

Alenka J Brooks1, Philip J Smith2, James O Lindsay3,4.   

Abstract

The transition of adolescents and young people (AYP) with inflammatory bowel disease (IBD) from paediatric to adult healthcare requires coordination between healthcare care providers to achieve optimum outcomes. Transition into adulthood is a time of major challenges physically, developmentally, emotionally and psychosocially for AYP living with IBD. Healthcare professionals must monitor the AYP progress proactively with attention to each of these parameters throughout the transition period to ensure that milestones are attained, and skills for self-management are formed. Thus, achieving the desired goals in both clinical and pastoral areas requires intensive monitoring from a multidisciplinary team across healthcare providers.

Entities:  

Keywords:  INFLAMMATORY BOWEL DISEASE

Year:  2017        PMID: 29484159      PMCID: PMC5824770          DOI: 10.1136/flgastro-2016-100747

Source DB:  PubMed          Journal:  Frontline Gastroenterol        ISSN: 2041-4137


  62 in total

Review 1.  Enough of the problem: a review of time for health care transition solutions for young adults with a chronic illness.

Authors:  P Rapley; P M Davidson
Journal:  J Clin Nurs       Date:  2010-02       Impact factor: 3.036

2.  'Down the rabbit hole': enhancing the transition process for youth with cystic fibrosis and congenital heart disease by re-imagining the future and time.

Authors:  F J Moola; M E Norman
Journal:  Child Care Health Dev       Date:  2011-11       Impact factor: 2.508

3.  Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial.

Authors:  Geert D'Haens; Filip Baert; Gert van Assche; Philip Caenepeel; Philippe Vergauwe; Hans Tuynman; Martine De Vos; Sander van Deventer; Larry Stitt; Allan Donner; Severine Vermeire; Frank J Van De Mierop; Jean-Charles R Coche; Janneke van der Woude; Thomas Ochsenkühn; Ad A van Bodegraven; Philippe P Van Hootegem; Guy L Lambrecht; Fazia Mana; Paul Rutgeerts; Brian G Feagan; Daniel Hommes
Journal:  Lancet       Date:  2008-02-23       Impact factor: 79.321

Review 4.  Young people first, juvenile idiopathic arthritis second: transitional care in rheumatology.

Authors:  Janet E McDonagh
Journal:  Arthritis Rheum       Date:  2008-08-15

5.  Body image dissatisfaction: clinical features, and psychosocial disability in inflammatory bowel disease.

Authors:  Edel McDermott; Georgina Mullen; Jenny Moloney; Denise Keegan; Kathryn Byrne; Glen A Doherty; Garret Cullen; Kevin Malone; Hugh E Mulcahy
Journal:  Inflamm Bowel Dis       Date:  2015-02       Impact factor: 5.325

6.  Randomized efficacy trial of two psychotherapies for depression in youth with inflammatory bowel disease.

Authors:  Eva Szigethy; Simona I Bujoreanu; Ada O Youk; John Weisz; David Benhayon; Diane Fairclough; Peter Ducharme; Joseph Gonzalez-Heydrich; David Keljo; Arvind Srinath; Athos Bousvaros; Margaret Kirshner; Melissa Newara; David Kupfer; David R DeMaso
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2014-05-10       Impact factor: 8.829

7.  Self-efficacy in adolescents with inflammatory bowel disease: a pilot study of the "IBD-yourself", a disease-specific questionnaire.

Authors:  Marieke Zijlstra; Charlotte De Bie; Laura Breij; Merel van Pieterson; Anneloes van Staa; Lissy de Ridder; Janneke van der Woude; Johanna Escher
Journal:  J Crohns Colitis       Date:  2013-03-26       Impact factor: 9.071

8.  Transition readiness in pediatric patients with inflammatory bowel disease: patient survey of self-management skills.

Authors:  Emily P Whitfield; Emily M Fredericks; Sally J Eder; Benjamin H Shpeen; Jeremy Adler
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-01       Impact factor: 2.839

9.  Predicting relapse in Crohn's disease: a biopsychosocial model.

Authors:  A Bitton; P L Dobkin; M D Edwardes; M J Sewitch; J B Meddings; S Rawal; A Cohen; S Vermeire; L Dufresne; D Franchimont; G E Wild
Journal:  Gut       Date:  2008-04-07       Impact factor: 23.059

10.  Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial.

Authors:  Reena Khanna; Brian Bressler; Barrett G Levesque; Guangyong Zou; Larry W Stitt; Gordon R Greenberg; Remo Panaccione; Alain Bitton; Pierre Paré; Séverine Vermeire; Geert D'Haens; Donald MacIntosh; William J Sandborn; Allan Donner; Margaret K Vandervoort; Joan C Morris; Brian G Feagan
Journal:  Lancet       Date:  2015-09-03       Impact factor: 79.321

View more
  3 in total

1.  Transition clinics: an observational study of themes important to young people with inflammatory bowel disease.

Authors:  Shwan Karim; Jody A Porter; Andrew McCombie; Richard B Gearry; Andrew S Day
Journal:  Transl Pediatr       Date:  2019-01

2.  Health Care Transition Outcomes in Inflammatory Bowel Disease: A Multinational Delphi Study.

Authors:  Gertrude van den Brink; Martha A C van Gaalen; Lissy de Ridder; C Janneke van der Woude; Johanna C Escher
Journal:  J Crohns Colitis       Date:  2019-09-19       Impact factor: 9.071

3.  Value of an outpatient transition clinic for young people with inflammatory bowel disease: a mixed-methods evaluation.

Authors:  Jane N T Sattoe; Mariëlle A C Peeters; Jannie Haitsma; AnneLoes van Staa; Victorien M Wolters; Johanna C Escher
Journal:  BMJ Open       Date:  2020-01-06       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.